Anti-PARP9 antibody (400-700 aa) (STJ11106176)

SKU:
STJ11106176
£112.50 - £524.50
Processing The item has been added

Host: Rabbit
Applications: WB/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality : Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:200-1:2000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: PARP9
Gene ID: 83666
Uniprot ID: PARP9_HUMAN
Immunogen Region: 400-700 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 400-700 of human PARP9 (NP_001139577.1).
Immunogen Sequence: MEIKKETAAEILFDEVLTFA KDHVKHQLTVKFVIFPTDLE IYKAFSSEMAKRSKMLSLNN YSVPQSTREEKRENGLEARS PAINLMGFNVEEMYEAHAWI QRILSLQNHHIIENNHILYL GRKEHDILSQLQKTSSVSIT EIISPGRTELEIEGARADLI EVVMNIEDMLCKVQEEMARK KERGLWRSLGQWTIQQQKTQ DEMKENIIFLKCPVPPTQEL LDQKKQFEKCGLQVLKVEK
Tissue Specificity Expressed in lymphocyte-rich tissues, spleen, lymph nodes, peripheral blood lymphocytes and colonic mucosa. Expressed in macrophages. Also expressed in nonhematopoietic tissues such as heart and skeletal muscle. Isoform 2 is the predominant form. Most abundantly expressed in lymphomas with a brisk host inflammatory response. In diffuse large B-cell lymphomas tumors, expressed specifically by malignant B-cells.
Post Translational Modifications ADP-ribosylated by PARP14.
Function ADP-ribosyltransferase which, in association with E3 ligase DTX3L, plays a role in DNA damage repair and in immune responses including interferon-mediated antiviral defenses. Within the complex, enhances DTX3L E3 ligase activity which is further enhanced by PARP9 binding to poly(ADP-ribose). In association with DTX3L and in presence of E1 and E2 enzymes, mediates NAD(+)-dependent mono-ADP-ribosylation of ubiquitin which prevents ubiquitin conjugation to substrates such as histones. During DNA repair, PARP1 recruits PARP9/BAL1-DTX3L complex to DNA damage sites via PARP9 binding to ribosylated PARP1. Subsequent PARP1-dependent PARP9/BAL1-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites. In response to DNA damage, PARP9-DTX3L complex is required for efficient non-homologous end joining (NHEJ).the complex function is negatively modulated by PARP9 activity. Dispensable for B-cell receptor (BCR) assembly through V(D)J recombination and class switch recombination (CSR). In macrophages, positively regulates pro-inflammatory cytokines production in response to IFNG stimulation by suppressing PARP14-mediated STAT1 ADP-ribosylation and thus promoting STAT1 phosphorylation. Also suppresses PARP14-mediated STAT6 ADP-ribosylation.
Protein Name Protein Mono-Adp-Ribosyltransferase Parp9
Adp-Ribosyltransferase Diphtheria Toxin-Like 9
Artd9
B Aggressive Lymphoma Protein
Poly Adp-Ribose Polymerase 9
Parp-9
Database Links Reactome: R-HSA-197264
Reactome: R-HSA-9683610
Reactome: R-HSA-9694631
Cellular Localisation Cytoplasm
Cytosol
Nucleus
Shuttles Between The Nucleus And The Cytosol
Translocates To The Nucleus In Response To Ifng Or Ifnb1 Stimulation
Export To The Cytosol Depends On The Interaction With Dtx3l
Localizes At Sites Of Dna Damage In A Parp1-Dependent Manner
Alternative Antibody Names Anti-Protein Mono-Adp-Ribosyltransferase Parp9 antibody
Anti-Adp-Ribosyltransferase Diphtheria Toxin-Like 9 antibody
Anti-Artd9 antibody
Anti-B Aggressive Lymphoma Protein antibody
Anti-Poly Adp-Ribose Polymerase 9 antibody
Anti-Parp-9 antibody
Anti-PARP9 antibody
Anti-BAL antibody
Anti-BAL1 antibody

Information sourced from Uniprot.org